BioXcel Therapeutics Inc

NASDAQ:BTAI  
44.45
-0.20 (-0.45%)
Earnings Announcements

BioXcel Therapeutics Reports Third Quarter 2020 Financial Results And Provides Business Update

Published: 11/12/2020 12:24 GMT
BioXcel Therapeutics Inc (BTAI) - Bioxcel Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update.
Bioxcel Therapeutics Inc - Strong Cash Position of $233 Million to Fund Key Milestones Well Into 2022.
Bioxcel Therapeutics Inc - Qtrly Loss per Share $1.07.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.92

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.99

More details on our Analysts Page.